Skip to content
OpenSampling

2025 · International journal of neonatal screening · open access

Sudden Death of a Four-Day-Old Newborn Due to Mitochondrial Trifunctional Protein/Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiencies and a Systematic Literature Review of Early Deaths of Neonates with Fatty Acid Oxidation Disorders

Drole Torkar et al.

The finding, in our words

A term newborn died at 4 days; newborn screening by tandem mass spectrometry on a dried blood spot indicated mitochondrial trifunctional protein or long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, and genetic analysis of the same DBS identified two HADHA variants, confirming the diagnosis; the authors review early neonatal deaths from fatty acid oxidation disorders and discuss limitations of newborn screening for these conditions, highlighting the role of DBS-based screening and post-mortem genetic testing in decentralised diagnostics.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2025

    Whole-genome sequencing of dried blood spots from 1,000 newborns identified 16 infants with high-chance results, most missed by standard screening. The 13-day turnaround and high parental acceptability show a feasible, scalable model for decentralised genomic screening.

    Feasibility, acceptability and clinical outcomes of the BabyScreen+ genomic newborn screening studyLunke et al., Nature medicine · source ↗

    • blood
    • dried
    • dbs
    • acceptability
    • pediatric
    • genotyping
  2. 2023

    Self-collection of dried blood spots in the home was feasible for healthy youth, with 82% consenting to provide a sample in the lab and 75% of those willing to self-collect at home, and DNA extraction quality was high across demographic groups.

    At-home dried blood spot (DBS) collection to increase population heterogeneity representation in pediatric research: An ECHO studyGreen et al., Frontiers in pediatrics · source ↗

    • acceptability
    • blood
    • dbs
    • self-collection
    • dried
    • pediatric
    • genotyping
  3. 2020

    A targeted NGS panel using dried blood spots achieved 100% concordance with Sanger sequencing in detecting pathogenic variants across 32 samples, with average coverage of 596X. This validates microsampling for decentralised newborn screening programmes, enabling accurate genetic diagnosis from minimally invasive specimens.

    A targeted gene capture next-generation sequencing panel for genetic screening of newbornsPeng et al., JPMA. The Journal of the Pakistan Medical Association (paywalled) · source ↗

    • blood
    • dried
    • dbs
    • validation
    • pediatric
    • genotyping
  4. 2016

    DNA from dried blood spots extracted with a home-made buffer yielded more DNA than a commercial kit at similar quality, and duplex allele-specific qPCR accurately identified all HLA-DQ2 and DQ8 alleles in 558 children, reducing genotyping costs by 60 per cent for population-wide celiac disease and type 1 diabetes screening.

    A population-wide applicable HLA-DQ2 and DQ8 genotyping using DNA from dried blood spots and duplex allele-specific qPCR amplificationAguayo-Patrón et al., Scandinavian journal of clinical and laboratory investigation (paywalled) · source ↗

    • blood
    • economics
    • dbs
    • dried
    • pediatric
    • validation
    • genotyping
  5. 2026

    Frequent dried blood spot sampling detected early changes in beta-cell function more effectively than mixed-meal tolerance tests or urine ratios, supporting its potential as a decentralised monitoring tool for clinical trials.

    Serial Dried Blood Spot C-Peptide Sampling, but Not Urine C-Peptide-to-Creatinine Ratio, Detects Early Preservation of β-Cell Function in New-Onset Type 1 Diabetes: Experience From the USTEKID TrialDunseath et al., Diabetes care (paywalled) · source ↗

    • dct
    • blood
    • dbs
    • dried
    • pediatric
    • urine
    • biomarkers